Inactive Instrument

News Basilea Pharmaceutica AG Xetra

Equities

PK5

CH0011432447

Summary

Unlock all the news: Be the first to know and act before the market!

Basilea Pharmaceutica : Updated June 28, 2024	28/06	PU
Basilea Pharmaceutica to Sell Brain Cancer Drug Candidate to US-based Nonprofit	20/06	MT
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation	20/06	DJ
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation	20/06	GL
Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales	16/05	MT
Strong Cresemba(R) (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	16/05	DJ
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	16/05	GL
Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024	03/05	GL
Basilea Reports Presentation of New Data for Ceftobiprole (Zevtera®) At Escmid Global 2024	03/05	CI
Basilea shareholders approve all proposals of the board of directors at the annual general meeting	24/04	GL
Basilea shareholders approve all proposals of the board of directors at the annual general meeting	24/04	AQ
Actym Therapeutics Appoints Thomas Smart as CEO	24/04	PR
Basilea Pharmaceutica Receives Grant for Antibiotics Program	09/04	MT
Basilea Pharmaceutica : Updated April 9, 2024	09/04	PU
Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics	09/04	GL
Stocks Close in Green as Swiss Inflation Unexpectedly Slows	04/04	MT
European stocks rise ahead of inflation data; Basilea shines	04/04	RE
Basilea Pharmaceutica : Updated April 4, 2024	04/04	PU
Basilea announces US FDA approval of antibiotic ZEVTERA(R) (ceftobiprole medocaril) for three indications	04/04	DJ
Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications	04/04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Basilea Pharmaceutica AG Xetra

Equities

PK5

CH0011432447

Summary

Filters